Literature DB >> 6202645

Plasminogen activators, activation inhibitors and alpha 2-macroglobulin produced by cultured normal and malignant human cells.

O Saksela, A Vaheri, W D Schleuning, P Mignatti, S Barlati.   

Abstract

In the present paper we have characterized the plasminogen activators (PA) synthesized by 25 different human cell lines. Technically easy methods were adopted for concentration and immunological characterization of the activators even in the presence of PA inhibitors. Most cell lines produced u-PA (mol. wt 55,000), melanoma and HeLa cells t-PA (mol. wt 66,000) and two carcinoma cell lines and normal skin fibroblasts produced no detectable PA. The classical 125I-fibrin method was compared to a caseinolytic assay and some of the discrepancies between results obtained with the two methods were shown to be due to cell-derived NaDodSO4-sensitive proteinase inhibitors in culture media. Additionally, synthesis and uptake by the cells of the wide-spectrum proteinase inhibitor alpha-2-macroglobulin ( alpha 2M ) were studied by radioimmunoassay and immunofluorescence. No production of alpha 2M could be measured in any of the malignant cell lines. In normal cells no correlation existed between the production of alpha 2M and the observed inhibition of PA activity, which indicates that other proteinase inhibitors are produced by the cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202645     DOI: 10.1002/ijc.2910330510

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Studies on rat mammary adenocarcinomas: a model for metastasis.

Authors:  I A Ramshaw; P Badenoch-Jones
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

2.  Soluble factors released by the target organ enhance the urokinase-type plasminogen activator activity of metastatic tumor cells.

Authors:  E Bal de Kier Joffé; D F Alonso; L Puricelli
Journal:  Clin Exp Metastasis       Date:  1991 Jan-Feb       Impact factor: 5.150

3.  Serum levels of some acute phase proteins in kidney and urinary tract urothelial cancers.

Authors:  M Pejovic; V Djordjevic; I Ignjatovic; T Stamenic; V Stefanovic
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator.

Authors:  V J Uitto; H Larjava; J Heino; T Sorsa
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

5.  Synthesis and secretion of alpha 2-macroglobulin by human glioma established cell lines.

Authors:  R Businaro; C Fabrizi; L Fumagalli; G M Lauro
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

6.  Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.

Authors:  Q Dong; M H Zhou; V Subbarao; C H Ts'ao
Journal:  Br J Exp Pathol       Date:  1988-10

7.  Localization of alpha 2-macroglobulin in human primary sarcomas and synthesis in established cell lines.

Authors:  M Grófová; E Larsson; A Bengtsson; J Bizik; B Westermark; J Pontén
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

8.  Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids.

Authors:  R L Medcalf; R I Richards; R J Crawford; J A Hamilton
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

9.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.

Authors:  R W Stephens; J Pöllänen; H Tapiovaara; K C Leung; P S Sim; E M Salonen; E Rønne; N Behrendt; K Danø; A Vaheri
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.